Effects of Frailty in Newly Diagnosed Patients With DLBCL
Posted: 09/13/2022 | By: Chase Doyle

In a study published by Vijenthira et al in JNCCN–Journal of the National Comprehensive Cancer Network, a research team sought to determine frailty is associated with survival in a population-based sample of patients with diffuse large B-cell lymphoma (DLBCL) and to describe the difference in health-care utilization between frail and nonfrail patients (if one was discovered).

Question 1 of 5

What percentage of patients with DLBCL who were classified as nonfrail died within 1 year of first-line treatment?

Choose 1